Review Article

The Great Healing Potential Hidden in Plant Preparations of Antioxidant Properties: A Return to Nature?

Table 13

The protective effects of plant origin materials in lung disorders.

ReferencePlant extract, dose, way and time of treatment, and animalsInducing factor and negative effectsProtective effects of plant materialEffects of plant per se

Taguchi et al. [118]Sakuranetin, a flavonoid obtained from methanol extract of aerial portions of Baccharis retusa by successive extraction and separation from CH2Cl2 phase
Posttreatment -20 mg/kg via intranasal instillation on days 0, 7, 14, and 28 (the end of the experiment)
C57BL6 male mice, 7-9-week-old, 25 g
Emphysema induced by elastase, 50 μL (6.6 units/mg), an intranasal drop (0.667 IU)
BALF: macrophages, lymphocytes, neutrophils, eosinophils, total cells ↑
Lung: NF-κB, M-CSF, IL-1β, MCP-1, TNF-α ↑, expression of TIMP-1, MMP-9, MMP-12 ↑
Lung: collagen and elastic fiber deposition ↑
BALF: eosinophils (-), macrophages, lymphocytes, neutrophils, total cells (++)
Lung: MCP-1 (+), M-CSF, IL-1β, TNF-α, NF-κB (+++), expression of TIMP-1 ↑, expression of MMP-9, MMP-12 (++)
Lung: collagen and elastic fiber deposition (++)
BALF: eosinophils ↑

Kaveh et al. [117]Portulaca oleracea leaves, 70% ethanol extract
1, 2 and 4 mg/mL in drinking water for 21 days
Male Wistar rats, about 220 g
Asthma rats sensitized on days 1, 2, and 3 by 1 mg/kg of ovalbumin (OVA)+100 mg Al(OH)3, i.p., and exposed to 1% OVA aerosol for 20 min on days 6, 9, 12, 15, 18, and 21
Serum: thiol, SOD, CAT ↓, NO2-, NO3-, MDA ↑
Blood: lymphocytes ↓, total WBC, eosinophils, neutrophils ↑
Serum: thiol and MDA (0 1, + 2, ++ 4), SOD (0 1, + 2, +++ 4), CAT (0 1, ++ 2 and 4), NO2- (++ 1, +++ 2 and 4), NO3- (++ all doses)
Blood: neutrophils and lymphocytes (0 1, ++ 2, +++ 4), eosinophils (0 1, +++ 2 and 4), total WBC (+++ all doses)
Not studied

Wang et al. [119]Salvia miltiorrhiza Bge. f. alba root aqueous extract
4.6 or 14 g/kg b.w. daily in the drinking water, 21 days after MCT
Male Sprague-Dawley rats, 200-220 g
Pulmonary hypertension animal model caused by monocrotaline (MCT)—a single dose of 60 mg/kg b.w., s.c.
Mean pulmonary artery pressure, right ventricular systolic pressure ↑
Plasma: NO, 6-Keto-PGF1α ↓, ET-1 and TXB2
Lung: TGF-β1 ↑
Mean pulmonary artery pressure and right ventricular systolic pressure (++ both doses)
Plasma: 6-Keto-PGF1α and TXB2 (++ both doses), NO, ET-1 (++ 4.6, +++ 14)
Lung: TGF-β1 (++ both doses)
Not studied

↓: a decrease vs. control; ↑: an increase vs. control; (+): a slight beneficial effect; (++): a distinct beneficial effect; (+++): a complete beneficial effect; (0): no beneficial effect; (-): intensification of the harmful effect.